Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Human Umbilical Cord Derived Mesenchymal Stromal Cells to Treat Steroid-Refractory Acute GvHD III/IV or Overlap Syndrome: Interim Analysis of a Multicenter Phase I/II Study

Maria Mico', Alessandra Algarotti, MD, Anna Grassi, MD, Chiara Pavoni, Statistician, Francesco Onida, MD, Nicola Mordini, Maria Luisa Ferrari, Federico Lussana, MD PhD, Maria Chiara Finazzi, MD, Daniela Taurino, MD, Chiara Capelli, Martino Introna, MD, Alessandro Rambaldi, MD PhD

Blood (2018) 132 (Supplement 1): 3404.

https://doi.org/10.1182/blood-2018-99-118444

Published: 2018

Journal Articles

Final Analysis of a Multicenter Pilot Phase 2 Study of Cytokine Induced Killer (CIK) Cells for Patients with Relapse after Allogeneic Transplantation

Blood (2016) 128 (22): 1160.

https://doi.org/10.1182/blood.V128.22.1160.1160

Published: 2016

Journal Articles

A Multicenter Phase II Study of Sequential Administration of Unmanipulated DLI and Donor Derived Cytokine Induced Killer (CIK) Cells in HSCT Patients, Relapsed of Disease

Martino Introna, MD, Elisa Gotti, BA, Michela Bonzi, BA, Josee Golay, PhDBA, Alessandra Algarotti, MD, Caterina Micò, MD, Anna Grassi, MD, Cristina Boschini, Maria Luisa Ferrari, BSc, Irene Cavattoni, MD, Ettore Biagi, MD, Adriana Balduzzi, Sr., MD, Attilio Rovelli, MD, Paolo Perseghin, MD, Giuseppe Gaipa, PhD, Andrea Biondi, Alessandro Rambaldi, MD

Blood (2015) 126 (23): 3160.

https://doi.org/10.1182/blood.V126.23.3160.3160

Published: 2015

Journal Articles

In Vivo T Cell Depletion with Antithymocyte Globulin or Alemtuzumab for Unrelated Donor Stem Cell Transplantation with Reduced Intensity Conditioning: Results of a Multicenter Randomized Phase II Clinical Trial (The Global Study) From the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

Blood (2012) 120 (21): 221.

https://doi.org/10.1182/blood.V120.21.221.221

Published: 2012

Journal Articles

Role of Front-Line High Dose Therapy with Stem Cell Transplant in Peripheral T-Cell Lymphomas. A Single Center Experience.

Giuseppe Gritti, MD, Andrea Rossi, MD, Anna Maria Barbui, MD, Anna Grassi, MD, Alessandra Algarotti, MD, Caterina Micò, MD, Federica Delaini, BiolSC, Alessandro Rambaldi, MD

Blood (2012) 120 (21): 2733.

https://doi.org/10.1182/blood.V120.21.2733.2733

Published: 2012

Journal Articles

Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients

Blood (2012) 120 (21): 743.

https://doi.org/10.1182/blood.V120.21.743.743

Published: 2012

Journal Articles

A Phase II Study of Sequential Administration of DLI and Cytokine Induced Killer (CIK) Cells in Patients with Hematologic Malignancies Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation: Preliminary Results

Martino Introna, MD, Alessandra Algarotti, MD, Caterina Micò, MD, Anna Grassi, MD, Alice Pievani, PhD, Gianmaria Borleri, Josée Golay, PhD, Irene Cavattoni, MD, Sergio Cortelazzo, MD, Alessandro Rambaldi

Blood (2011) 118 (21): 657.

https://doi.org/10.1182/blood.V118.21.657.657

Published: 2011

Journal Articles

Understanding the Immunomodulatory Effect of Mesenchymal Stem Cell Infused In Transplanted Patients with Steroid-Refractory GvHD

Erica Dander, PhD, Giovanna Lucchini, MD, Paola Vinci, Martino Introna, MD, Sonia Bonanomi, MD, Adriana Balduzzi, MD, Giuseppe Gaipa, PhD, Paolo Perseghin, MD, Francesca Masciocchi, Chiara Capelli, PhD, Josée Golay, PhD, Alessandra Algarotti, MD, Alessandro Rambaldi, MD, Attilio Rovelli, MD, Andrea Biondi, MD, Ettore Biagi, MD, Giovanna D'Amico, PhD

Blood (2010) 116 (21): 2306.

https://doi.org/10.1182/blood.V116.21.2306.2306

Published: 2010

Journal Articles

Human Metapneumovirus Infection in Adult Patients after Allogeneic Hemopoietic Stem Cell Transplantation.

Anna A. Colombo, MD, Alessandra Algarotti, MD, Maurizia Debiaggi, PhD, Maurizio Parea, MD, Letizia Zenone Bragotti, MD, Paolo Bernasconi, MD, Daniela Caldera, MD, Filippo Canducci, MD, Mario Lazzarino, MD, Emilio P. Alessandrino, MD

Blood (2005) 106 (11): 3228.

https://doi.org/10.1182/blood.V106.11.3228.3228

Published: 2005

Journal Articles

Evolution of a True B-Cell Chronic Lymphocytic Leukaemia (B-CLL) in a Diffuse Immunocytoma after Treatment with Fludarabine.

Paolo Bernasconi, MD, Marco Paulli, MD, Ester Orlandi, MD, Vittorio Perfetti, MD, Ilaria Giardini, MD, Silvia Zibellini, MD, Laura Vanelli, MD, Annamaria Tenore, MD, Marina Boni, MD, Paola Maria Cavigliano, MD, Alessandra Algarotti, MD, Ercole Brusamolino, MD, Mario Lazzarino, MD

Blood (2005) 106 (11): 4973.

https://doi.org/10.1182/blood.V106.11.4973.4973

Published: 2005

Journal Articles

High Dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma: Comparison of Four Preparative Regimens.

Emilio P. Alessandrino, MD, Letizia Zenone Bragotti, MD, Anna A. Colombo, MD, Alessandra Algarotti, MD, Paolo Bernasconi, MD, Margherita Maffioli, MD, Daniela Caldera, MD, Alessandro Corso, MD, Elisa Rumi, MD, Daniela Troletti, PhD, Mario Lazzarino

Blood (2005) 106 (11): 5489.

https://doi.org/10.1182/blood.V106.11.5489.5489

Published: 2005

NARROW

Human Umbilical Cord Derived Mesenchymal Stromal Cells to Treat Steroid-Refractory Acute GvHD III/IV or Overlap Syndrome: Interim Analysis of a Multicenter Phase I/II Study

Final Analysis of a Multicenter Pilot Phase 2 Study of Cytokine Induced Killer (CIK) Cells for Patients with Relapse after Allogeneic Transplantation

A Multicenter Phase II Study of Sequential Administration of Unmanipulated DLI and Donor Derived Cytokine Induced Killer (CIK) Cells in HSCT Patients, Relapsed of Disease

In Vivo T Cell Depletion with Antithymocyte Globulin or Alemtuzumab for Unrelated Donor Stem Cell Transplantation with Reduced Intensity Conditioning: Results of a Multicenter Randomized Phase II Clinical Trial (The Global Study) From the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

Role of Front-Line High Dose Therapy with Stem Cell Transplant in Peripheral T-Cell Lymphomas. A Single Center Experience.

Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients

A Phase II Study of Sequential Administration of DLI and Cytokine Induced Killer (CIK) Cells in Patients with Hematologic Malignancies Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation: Preliminary Results

Understanding the Immunomodulatory Effect of Mesenchymal Stem Cell Infused In Transplanted Patients with Steroid-Refractory GvHD

Human Metapneumovirus Infection in Adult Patients after Allogeneic Hemopoietic Stem Cell Transplantation.

Evolution of a True B-Cell Chronic Lymphocytic Leukaemia (B-CLL) in a Diffuse Immunocytoma after Treatment with Fludarabine.

High Dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma: Comparison of Four Preparative Regimens.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only